Strategic Program Lead, MariTide, OSA & PIE

Initial Therapeutics, Inc.

United States

Hybrid

USD 180,000 - 260,000

Full time

14 days+
Application generator

Turn this role into an interview — a resume and cover letter built around what this employer wants.

Get past ATS filters

Benefits offered by this job

Flexible work models where possible

Job summary

Amgen is seeking a senior program leader to shape and drive enterprise-wide execution across obesity-related indications, including OSA and PIE initiatives. You will orchestrate cross-functional decisions, manage strategic portfolios, and align development, medical, regulatory, and commercial teams to deliver milestones that maximize patient and business impact.

Applicants should possess advanced degrees in biopharmaceuticals and a track record leading complex programs with strong stakeholder

Qualifications

  • Doctorate degree with 5+ years in biopharmaceutical commercialization, global strategy execution, or program management.
  • Masters degree with 8+ years in biopharmaceutical commercialization, global strategy execution, or program management.
  • Bachelors degree with 10 years in biopharmaceutical commercialization, global strategy execution, or program management.
  • Strong consulting, data analysis, stakeholder management, and cross-functional leadership experience.

Responsibilities

  • Lead enterprise portfolio integration across OSA and PIE initiatives, ensuring alignment across development, medical, regulatory, commercial, and operations functions.
  • Shape and operationalize the integrated program plan and critical timelines, driving accountability, visibility, and delivery against key milestones.
  • Drive execution across Global Development, Medical, Commercial, Regulatory, Market Access, and Operations functions to ensure successful execution of interconnected portfolio initiatives.
  • Translate strategy into actionable plans, ensuring clear linkage between global objectives and operational effectiveness to support launch readiness and lifecycle management.
  • Lead cross-functional planning processes and ensure linkage between global strategy, business priorities, and operational execution.

Skills

Cross-Functional Influence
Strategic Execution
Program Management
Stakeholder Management
Decision Enablement

Education

Doctorate degree
Masters degree
Bachelors degree

Job description

Amgen is seeking a senior program leader to shape and drive enterprise-wide execution across obesity-related indications, including OSA and PIE initiatives. You will orchestrate cross-functional decisions, manage strategic portfolios, and align development, medical, regulatory, and commercial teams to deliver milestones that maximize patient and business impact.

Applicants should possess advanced degrees in biopharmaceuticals and a track record leading complex programs with strong stakeholder

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Global Program Execution Lead
Global Program Execution Lead

amgen • United States

Hybrid
USD 180,000 - 243,000
Retirement plan
Stock-based incentives
Flexible work models
+1
Senior Program Execution Lead: OSA & PIE
Senior Program Execution Lead: OSA & PIE

Biopharma Careers • United States

Hybrid
USD 180,000 - 243,000
Retirement plan
Medical, dental, vision coverage
Life and disability insurance
+5
Global Program Execution Director, Obesity & OSA
Global Program Execution Director, Obesity & OSA

Scorpion Therapeutics • United States

Hybrid
USD 150,000 - 210,000
MariTide, OSA and PIE Program Execution Lead, Senior Director
MariTide, OSA and PIE Program Execution Lead, Senior Director

Scorpion Therapeutics • United States

Hybrid
USD 150,000 - 210,000
MariTide, OSA and PIE Program Execution Lead, Senior Director
MariTide, OSA and PIE Program Execution Lead, Senior Director

Biopharma Careers • United States

Hybrid
USD 180,000 - 243,000
Retirement plan
Medical, dental, vision coverage
Life and disability insurance
+5
MariTide, OSA and PIE Program Execution Lead
MariTide, OSA and PIE Program Execution Lead

amgen • United States

Hybrid
USD 180,000 - 243,000
Retirement plan
Stock-based incentives
Flexible work models
+1
Director, Strategic Initiatives — Obesity Growth
Director, Strategic Initiatives — Obesity Growth

Initial Therapeutics, Inc. • United States

On-site
USD 180,000 - 280,000
Director, Global Obesity Communications & Strategy
Director, Global Obesity Communications & Strategy

BioSpace • Washington

On-site
USD 180,000 - 280,000
Competitive benefits package
Flexible work model
Stock-based long-term incentives
MariTide, OSA and PIE Program Execution Lead, Senior Director
MariTide, OSA and PIE Program Execution Lead, Senior Director

Initial Therapeutics, Inc. • United States

Hybrid
USD 180,000 - 260,000
Flexible work models where possible
Senior Director, Global Obesity Insights & Strategy
Senior Director, Global Obesity Insights & Strategy

Amgen SA • Thousand Oaks (CA)

On-site
USD 210,000 - 300,000
Retirement and Savings Plan
Medical/Dental/Vision coverage
Life and Disability Insurance
+5